Log In
Print
BCIQ
Print
Print this Print this
 

CAL-120

  Manage Alerts
Collapse Summary General Information
Company Gilead Sciences Inc.
DescriptionOral, small molecule, delta and beta isoform selective phosphoinositide 3-kinase (PI3K) inhibitor
Molecular Target Phosphoinositide 3-kinase (PI3K) delta ; Phosphoinositide 3-kinase (PI3K) beta
Mechanism of ActionPhosphoinositide 3-kinase (PI3K) delta inhibitor; Phosphoinositide 3-kinase (PI3K) beta inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationSolid tumors
Indication DetailsTreat solid tumor malignancies
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today